Cardiovascular disease and diabetes
DOI:
https://doi.org/10.47196/diab.v54i2Sup.249Keywords:
cardiovascular disease, diabetes, risk factor'sAbstract
According to the World Health Organization (WHO), of the 57 million global deaths / year in the world, 71% is due to non-communicable diseases and, within them, more than half to cardiovascular disease. Hypertension, smoking, high blood glucose, physical inactivity, being overweight and obese, and high cholesterol levels are among the main risk factors for death worldwide. Most of these factors are associated with the incidence of cardiovascular disease (CVD) and diabetes mellitus (DM), and patients with DM have a high prevalence of most risk factors.
References
I. Narayan KM, Ali MK, Koplan JP. Global noncommunicable diseases–where worlds meet. N Engl J Med 2010; 363:196-1198.
II. Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation 2016; 133:187-225.
III. Zhang X, Devlin HM, Smith B, et al. Effect of lifestyle interventions on cardiovascular risk factors among adults without impaired glucose tolerance or diabetes: a systematic review and meta-analysis. PLoS One 2017; 12:e0176436.
IV. Centers for Disease Control and Prevention. National diabetes statistics report, 2017. Atlanta (GA): Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services, 2017.
V. American Heart Association. My Life Check: Life’s Simple 7. American Heart Association Web site. Disponible en: http://mylifecheck.heart.org/. Accessed August 22, 2017.
VI. Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation 2010; 121:586-613.
VII. Rawshani A, Sattar N, Franzen S, et al. Relative prognostic importance and optimal levels of risk factors for mortality and cardiovascular outcomes in type 1 diabetes mellitus. Circulation 2019; 139(6):1900-1012.
VIII. Htay T, Soe K, López-Pérez A, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. Current Cardiology Reports; 2019:21:45.
IX. Huxley RR, Peters SA, Mishra GD, et al. Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 2015; 3:198-206.
X. Peters SA, Huxley RR, Woodward M, et al. Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia 2014; 57:1542-51.
XI. Gilbert RE, Krum H. Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy. Lancet. 2015 May 23; 385(9982):2107-17.
XII. Perel C. Insuficiencia cardíaca y diabetes. Nuevos tratamientos para la diabetes. Insuficiencia Cardíaca 2018; 13(4):155-69.
XIII. Dunlay SM, Roger VL. Understanding the epidemic of heart failure: past, present, and future. Curr Heart Fail Rep 2014 Dec; 11(4):404-15.
XIV. Amato L, Paolisso G, Cacciatore F, Ferrara N, Ferrara P, Canonico S, Varricchio M, Rengo F. Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group. Diabetes Metab 1997 Jun; 23(3):213-8.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
